KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.
about
KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@en
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@nl
type
label
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@en
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@nl
prefLabel
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@en
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@nl
P2093
P2860
P356
P1476
KDM3A inhibition attenuates hi ...... ppressing MAPK/NF‑κB pathways.
@en
P2093
P2860
P304
P356
10.3892/IJMM.2017.3351
P577
2017-12-29T00:00:00Z